RSV is a well-known activator of SIRT1 (Csiszar et al., 2008
A 2025 post-hoc analysis of the SURMOUNT clinical trials, conducted by researchers at NewYork-Presbyterian and Weill Cornell Medicine, examined results from 2,542 women across premenopausal, perimenopausal, and postmenopausal stages
Once you have reached a stable weight, many patients choose to address loose skin or stubborn fat pockets with body contouring treatments
The key molecular pathway identified involves the activation of the general control nonderepressible 2 (GCN2) kinase, leading to the phosphorylation of eukaryotic initiation factor 2 alpha (eIF2) and the upregulation of ATF4
Both have similar side effects (like nausea) that improve over time
Michael Levin, PhD, FRCPCH 15